Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
KEWAUNEE SCIENTIFIC CORP (KEQU)
|
|
Income Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Apr-30-23 | Jan-31-23 | Oct-31-22 | Jul-31-22 | Apr-30-22 | Jan-31-22 | Oct-31-21 | Jul-31-21 |
| 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Revenues: |
Domestic | 35.1 | 36.1 | 38.0 | 37.5 | 37.7 | 29.5 | 29.9 | 29.7 |
International | 18.9 | 24.7 | 16.6 | 12.7 | 12.0 | 11.1 | 9.1 | 9.8 |
Total revenues [+] | 54.0 | 60.8 | 54.6 | 50.1 | 49.7 | 40.6 | 39.0 | 39.5 |
Products | 54.0 | 60.8 | 54.6 | 50.1 | 49.7 | 40.6 | 39.0 | 39.5 |
Net interest income | -0.5 | -0.4 | -0.4 | -0.4 | -0.2 | -0.2 | -0.1 | -0.1 |
Other income | 0.2 | 0.2 | 0.1 | 0.5 | 0.3 | 0.1 | 0.0 | 0.1 |
Revenue growth [+] | 8.6% | 49.7% | 39.8% | 26.9% | 28.4% | 21.9% | 0.1% | 8.4% |
Domestic | -6.9% | 22.4% | 26.9% | 26.3% | 39.0% | 17.8% | 4.0% | -1.3% |
International | 57.3% | 122.4% | 82.2% | 28.7% | 3.7% | 34.2% | -11.1% | 54.4% |
Cost of goods sold | 43.6 | 50.5 | 45.9 | 43.9 | 40.4 | 35.0 | 35.4 | 33.8 |
Gross profit | 10.4 | 10.3 | 8.7 | 6.2 | 9.3 | 5.6 | 3.6 | 5.7 |
Gross margin | 19.2% | 17.0% | 15.9% | 12.4% | 18.8% | 13.8% | 9.2% | 14.4% |
Selling, general and administrative [+] | 7.7 | 8.0 | 7.9 | 6.6 | 7.1 | 6.5 | 6.5 | 6.8 |
General and administrative | 7.7 | | | | 7.1 | | | |
EBITDA [+] | 3.4 | 3.0 | 1.5 | 0.3 | 2.9 | -0.2 | -2.2 | -0.4 |
EBITDA growth | 17.4% | -1851.7% | -166.9% | -182.7% | 9962.1% | -160.8% | -437.5% | -196.8% |
EBITDA margin | 6.3% | 5.0% | 2.7% | 0.7% | 5.9% | -0.4% | -5.6% | -1.0% |
Depreciation and amortization | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
EBIT [+] | 2.7 | 2.3 | 0.8 | -0.4 | 2.2 | -0.9 | -2.9 | -1.1 |
EBIT growth | 20.5% | -365.4% | -126.1% | -63.7% | -443.2% | 130.9% | 26172.7% | 295.3% |
EBIT margin | 5.0% | 3.8% | 1.4% | -0.8% | 4.5% | -2.1% | -7.4% | -2.8% |
Other income (expense), net | -0.4 | -0.2 | -0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Pre-tax income | 2.3 | 2.1 | 0.5 | -0.3 | 2.3 | -0.9 | -2.9 | -1.1 |
Income taxes | 1.2 | 1.0 | 0.6 | 0.4 | 2.7 | 0.4 | 0.2 | 0.3 |
Tax rate | 52.9% | 46.7% | 125.0% | | 114.0% | | | |
Minority interest | 0.1 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net income | 1.0 | 0.7 | -0.2 | -0.7 | -0.4 | -1.3 | -3.1 | -1.3 |
Net margin | 1.9% | 1.2% | -0.4% | -1.5% | -0.7% | -3.2% | -7.9% | -3.4% |
|
Basic EPS [+] | $0.36 | $0.26 | ($0.09) | ($0.27) | ($0.13) | ($0.47) | ($1.11) | ($0.48) |
Growth | -373.9% | -154.0% | -92.3% | -45.1% | -87.9% | -1712.1% | 1603.7% | 123.2% |
Diluted EPS [+] | $0.35 | $0.25 | ($0.09) | ($0.27) | ($0.13) | ($0.47) | ($1.11) | ($0.48) |
Growth | -366.5% | -152.5% | -92.3% | -45.1% | -87.9% | -1727.8% | 1603.7% | 123.2% |
|
|
Shares outstanding (basic) [+] | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 |
Growth | 1.4% | 1.4% | 1.5% | 1.1% | 0.9% | 1.0% | 1.1% | 0.8% |
Shares outstanding (diluted) [+] | 2.9 | 2.9 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 | 2.8 |
Growth | 4.2% | 4.3% | 1.5% | 1.1% | 0.9% | 0.0% | 1.1% | 0.8% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|